J&J Hopes To Reach Market First For Pre-Metastatic Prostate Cancer With Apalutamide

 
• By Joseph Haas

Janssen hasn’t released Phase III data yet but says the next-generation androgen receptor inhibitor showed potential benefit for metastasis-free survival.

Cancer cell division of two prostate cancer cells in the final stage of cell division (cytokinesis) cytoplasm divides. the cells are joined by several thin cytoplasmic bridges. They to form tumours

More from Anticancer

More from Therapy Areas